ZYNQUISTA Trademark

Trademark Overview

On Friday, September 29, 2017, a trademark application was filed for ZYNQUISTA with the United States Patent and Trademark Office. The USPTO has given the ZYNQUISTA trademark a serial number of 87628588. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, January 30, 2025. This trademark is owned by Sanofi. The ZYNQUISTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of sleep disorders, insomnia, and narcolepsy
zynquista

General Information

Serial Number87628588
Word MarkZYNQUISTA
Filing DateFriday, September 29, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 30, 2025
Registration Number5553403
Registration DateTuesday, September 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 4, after diabetes; (semicolon) all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of sleep disorders, insomnia, and narcolepsy should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment of diabetes; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of sleep disorders, insomnia, and narcolepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 5, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLEXICON PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressThe Woodlands, TX 77381
Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Wednesday, October 25, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 3, 2017NEW APPLICATION ENTERED
Thursday, October 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 17, 2017ASSIGNED TO EXAMINER
Wednesday, October 25, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, October 25, 2017SUSPENSION LETTER WRITTEN
Tuesday, January 30, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 7, 2018ASSIGNED TO LIE
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 16, 2018ASSIGNED TO PETITION STAFF
Thursday, April 19, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, July 29, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, July 30, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, August 16, 2018POST PUBLICATION AMENDMENT – NOT ENTERED
Tuesday, September 4, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, September 11, 2018TEAS SECTION 7 REQUEST RECEIVED
Wednesday, November 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 26, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 28, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, November 13, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 16, 2021TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, November 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 30, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 19, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, December 20, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

zynquista treatment preparations pharmaceutical disorders narcolepsy sleep insomnia excluding diabetes foregoing